Publisher Correction: COVID-19-associated acute kidney injury: consensus report of the 25th Acute Disease Quality Initiative (ADQI) Workgroup.

Geriatric Faculty Continue to Play Key Roles in SF's Coordinated Response to COVID

As part of the city's coordinated response to COVID, several faculty continue to be deployed and have assumed new roles. For three months, Anna Chodos, MD will be serving as the medical expert and lead for nursing home outbreaks in the Outbreak Management Group.  Louise Aronson, MD is now the medical expert and lead for the Senior Sites Team in the Community Mitigation Group. Meredith Greene, MD continues to be an expert on the care of older adults living with HIV in congregate settings for the Senior Sites Team, and Jeffrey Newman, MD joined the team and will be contributing his public and population health expertise.

Mortality and Function After Widowhood Among Older Adults With Dementia, Cancer, or Organ Failure.

Tie-2Cre mediated deletion of the vitamin D receptor gene leads to improved skeletal muscle insulin sensitivity and glucose tolerance.

Medicare and care coordination: expanding the clinician's toolbox.

Long-acting ART and preexposure prophylaxis: profound promise but stunted access.

How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation?

Pneumocystis carinii pneumonia: diagnosis.

A novel cause of chronic viral meningoencephalitis: Cache Valley virus.

Association of Race and Ethnicity With COVID-19 Outcomes in Rheumatic Disease: Data From the COVID-19 Global Rheumatology Alliance Physician Registry.

Factors Associated with Malpractice Claim Payout: An Analysis of Closed Emergency Department Claims.

Leadership Transition in the UCSF School of Medicine Vice Dean's Office at ZSFG

Elena Fuentes-Afflick, MD, MPH will step down as Vice Dean of UCSF School of Medicine at ZSFG in July 2024 to become the Chief Scientific Officer of the Association of American Medical Colleges. Since 2022, she has led key initiatives, including the opening of UCSF Pride Hall, and previously served as Vice Dean for Academic Affairs for 10 years. A passionate advocate for diversity, equity, and inclusion, Dr. Fuentes-Afflick has focused her research on immigrant health and health disparities. She has held significant leadership roles in national organizations, including the National Academy of Medicine.

Abstract OT-21-01: Personalized breast cancer screening in a population-based study: Women informed to screen depending on measures of risk (WISDOM).

A 24-week, randomized, double-blind, placebo-controlled, parallel group study of the efficacy of oral SCIO-469, a p38 mitogen-activated protein kinase inhibitor, in patients with active rheumatoid arthritis.

Human T cells in the SCID-hu mouse are phenotypically normal and functionally competent.